Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.

L. D. Sabath; D. A. Gerstein; P. B. Loder; M. Finland

Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.

L. D. Sabath
, D. A. Gerstein
, P. B. Loder
, M. Finland

Medicine - Infectious Disease and International Medicine

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	916-923
Number of pages	8
Journal	Journal of Laboratory and Clinical Medicine
Volume	72
Issue number	6
State	Published - 1968

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Acetazolamide/ur [Urine]
Adult
Anti-Infective Agents, Urinary
Bicarbonates/ur [Urine]
Clinical Trials as Topic
Erythromycin/pd [Pharmacology]
Erythromycin/ur [Urine]
Escherichia coli/de [Drug Effects]
Humans
Hydrogen-Ion Concentration
Klebsiella/de [Drug Effects]
Male
Proteus/de [Drug Effects]
Pseudomonas aeruginosa/de [Drug Effects]
Serratia/de [Drug Effects]

Find It

Find It at U of M Libraries

Cite this

@article{ddeac1f1e2474acba1fe8ee9fbb00451,

title = "Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.",

keywords = "Acetazolamide/ur [Urine], Adult, Anti-Infective Agents, Urinary, Bicarbonates/ur [Urine], Clinical Trials as Topic, Erythromycin/pd [Pharmacology], Erythromycin/ur [Urine], Escherichia coli/de [Drug Effects], Humans, Hydrogen-Ion Concentration, Klebsiella/de [Drug Effects], Male, Proteus/de [Drug Effects], Pseudomonas aeruginosa/de [Drug Effects], Serratia/de [Drug Effects]",

author = "Sabath, \{L. D.\} and Gerstein, \{D. A.\} and Loder, \{P. B.\} and M. Finland",

year = "1968",

language = "Undefined/Unknown",

volume = "72",

pages = "916--923",

journal = "Journal of Laboratory and Clinical Medicine",

issn = "0022-2143",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.

AU - Sabath, L. D.

AU - Gerstein, D. A.

AU - Loder, P. B.

AU - Finland, M.

PY - 1968

Y1 - 1968

KW - Acetazolamide/ur [Urine]

KW - Adult

KW - Anti-Infective Agents, Urinary

KW - Bicarbonates/ur [Urine]

KW - Clinical Trials as Topic

KW - Erythromycin/pd [Pharmacology]

KW - Erythromycin/ur [Urine]

KW - Escherichia coli/de [Drug Effects]

KW - Humans

KW - Hydrogen-Ion Concentration

KW - Klebsiella/de [Drug Effects]

KW - Male

KW - Proteus/de [Drug Effects]

KW - Pseudomonas aeruginosa/de [Drug Effects]

KW - Serratia/de [Drug Effects]

M3 - Article

C2 - 4972710

SN - 0022-2143

VL - 72

SP - 916

EP - 923

JO - Journal of Laboratory and Clinical Medicine

JF - Journal of Laboratory and Clinical Medicine

IS - 6

ER -